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Diabetes mellitus (DM) is considered a risk factor for cognitive dysfunction. Harmine not
only effectively improves the symptoms of DM but also provides neuroprotective effects in
central nervous system diseases. However, whether harmine has an effect on diabetes-
induced cognitive dysfunction and the underlying mechanisms remain unknown. In this
study, the learning and memory abilities of rats were evaluated by the Morris water maze
test. Changes in the nucleotide-binding oligomerization domain-containing protein (NOD)-
like receptor family, pyrin domain containing 3 (NLRP3) inflammasome and brain-derived
neurotrophic factor (BDNF)/TrkB signaling pathway were determined in both
streptozotocin (STZ)-induced diabetic rats and high glucose (HG)-treated SH-SY5Y
cells by western blotting and histochemistry. Herein, we found that harmine
administration significantly ameliorated learning and memory impairment in diabetic
rats. Further study showed that harmine inhibited NLRP3 inflammasome activation, as
demonstrated by reduced NLRP3, ASC, cleaved caspase-1, IL-1b, and IL-18 levels, in
the cortex of harmine-treated rats with DM. Harmine was observed to have similar
beneficial effects in HG-treated neuronal cells. Moreover, we found that harmine treatment
enhanced BDNF and phosphorylated TrkB levels in both the cortex of STZ-induced
diabetic rats and HG-treated cells. These data indicate that harmine mitigates cognitive
impairment by inhibiting NLRP3 inflammasome activation and enhancing the BDNF/TrkB
signaling pathway. Thus, our findings suggest that harmine is a potential therapeutic drug
for diabetes-induced cognitive dysfunction.
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Diabetes mellitus (DM) is a chronic metabolic disease and a
global epidemic (Sun et al., 2020). In 2019, the number of people
suffering from DM worldwide was estimated to be 463 million,
and this number is predicted to rise to 700 million in 2045
(International Diabetes Federation, https://www.diabetesatlas.
org/). Epidemiological surveys have revealed that DM patients
are at a higher risk to develop dementia (Morris et al., 2014;
Zhang et al., 2018; Chornenkyy et al., 2019). Clinical studies have
also shown that dementia and DM share many pathological
features, such as cerebral atrophy and neurodegeneration (Korf
et al., 2007; Kumar et al., 2008). Hyperglycemia, impaired insulin
signaling, vascular dysfunction, and inflammation are considered
to be contributors to diabetic-induced neurodegeneration and
cognitive dysfunction (Sonnen et al., 2009; Kimura, 2016; Duarte
et al., 2020).
Recent studies have clearly shown that the inflammasome is
involved in the pathogenesis of central nervous system diseases by
triggering interleukin (IL)-1b and IL-18 maturation (Ahmed et al.,
2017; White et al., 2017; Du et al., 2018). The nucleotide-binding
oligomerization domain-containing protein (NOD)-like receptor
family, pyrin domain containing 3 (NLRP3) inflammasome is a
well-known inflammasome that is associated with multiple
neurodegenerative diseases. However, inactivation of the NLRP3
inflammasome can ameliorate these diseases (Lu et al., 2016; Sarkar
et al., 2017; La Rosa et al., 2019; Swanson et al., 2019; Fox et al.,
2020). DM-related studies have also revealed that NLRP3
inflammasome activation is involved in several diabetic
complications, such as diabetic cardiomyopathy, diabetic
nephropathy, and diabetic retinopathy (Yu et al., 2020). NLRP3
inflammasome activation is observed in the brains of db/db mice, a
diabetic model that exhibits cognitive dysfunction (Zhai et al., 2018).
Moreover, high glucose (HG) has been found to induce NLRP3
inflammasome activation in neurons (Ward and Ergul, 2016). These
findings suggest that the NLRP3 inflammasome might be associated
with the progression of diabetes-induced cognitive dysfunction.
Harmine is an analogous b-carboline alkaloid compound and
possesses various biological functions. For example, harmine has
been found to influence b-cell proliferation and induce adipocyte
thermogenesis in the progression of DM (Dirice et al., 2016; Nie
et al., 2016). Harmine can treat multiple cancers by increasing cell
apoptosis, inhibiting CDKs and suppressing the AKT/mTOR
signaling pathway (Song et al., 2004; Ding et al., 2019; Wu et al.,
2019). Moreover, harmine also has a variety of effects, including
antioxidative, anti-inflammatory, anti-hypertensive, and
antidepressant effects, in the central nervous system (Li et al.,
2018). Previous studies have revealed that harmine can ameliorate
learning and memory impairment in scopolamine-induced animals
(He et al., 2015; Li et al., 2018). However, whether harmine can
improve cognitive dysfunction in diabetic rats is still unclear.Abbreviations: ASC, adaptor protein apoptosis-associated speck-like protein;
BDNF, brain-derived neurotrophic factor; DM, diabetes mellitus; FBG, fasting
blood glucose; Har, harmine; HG, high glucose; IL-1b, Interleukin-1b; IL-18,
Interleukin-18; ND, non-diabetes; NLRP3, nucleotide-binding oligomerization
domain-containing protein (NOD)-like receptor family, pyrin domain containing
3; p-TrkB, phosphorylated TrkB; STZ, Streptozotin.
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effect of harmine on the cognitive dysfunction induced by DM
and to explore the underlying molecular mechanisms. Our in
vivo and in vitro experiments provided strong evidence that
harmine is a neuroprotective agent that acts by inhibiting NLRP3
inflammasome activation and enhancing BDNF/TrkB
signaling pathway.MATERIALS AND METHODS
Model of Diabetes Mellitus and
Pharmacotherapy
Male Sprague-Dawley rats (weight, 180–220 g) were obtained
from the Animal Center of the Second Affiliated Hospital of
Harbin Medical University (China). The rats were housed in a
temperature (23 ± 1°C)- and humidity (55 ± 5%)-controlled
environment with free access to food and water. A model of
diabetes mellitus (DM) was established as described in our
previous studies (Meng et al., 2019; Che et al., 2020). Briefly,
the rats received a single intraperitoneal injection of 60 mg/kg
streptozotocin (STZ) dissolved in citrate buffer (pH = 4.5). Fasting
blood glucose (FBG) levels were detected 3 days after STZ
injection. Rats with FBG levels >16.7 mmol/L were considered
diabetic. Diabetic model rats were randomly divided into the DM
group and the DM plus harmine treatment (DM + har) group.
Beginning on day 4 after STZ injection, the rats in the DM + har
group (n = 8) were given harmine (20 mg/kg) by oral gavage for
12 weeks. The rats in the DM group (n = 8) and nondiabetic (ND)
group (n = 8) were orally administered an equal volume of 0.9%
saline solution daily.
Morris Water Maze
To determine the effect of harmine on cognitive function in
diabetic rats, we subjected the rats to the Morris water maze test
after 12 weeks of intervention. Briefly, the escape platform was
placed in the first quadrant (2 cm under the surface of the water).
On the first day, each rat was placed into the water facing the
pool wall and then allowed to find the escape platform within
120 s by itself. If the rat failed to find the target within a specified
time, one of the experimenters guided it to the platform and
allowed it to rest for at least 20 s. Training was performed for 5
days. The probe trial, in which the escape platform was removed
from the first quadrant, and each rat underwent a 120 s swim
trial, was performed on the sixth day. The swim distance, escape
latency, number of platform crossings in the target quadrant, and
time spent in the target quadrant were recorded by the
DigBehav-Morris Water Maze Video Analysis System.
Cell Culture and Treatment
Human SH-SY5Y neuroblastoma cells were cultured at a density
of 1×106 cells/well in 6-well plates with Dulbecco's modified
Eagle's medium containing 10% fetal bovine serum (FBS), 100
units/ml penicillin, and 100 mg/ml streptomycin. The cells were
incubated in a common incubator with 5% CO2 and 95% O2 at
37°C. The medium was replaced every two days. When theMay 2020 | Volume 11 | Article 535
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were exposed to HG (33 mM) conditions and treated with or
without harmine (1 mM) for 48 h.
Western Blot Analysis
Protein samples were extracted from rats from the different
groups and SH-SY5Y cells for immunoblotting analysis.
Briefly, the rats were anesthetized with 10% chloral hydrate
(500 mg/kg, intraperitoneal) and then killed by cervical
dislocation. The brain tissues were removed and homogenized
in 1,000 ml RIPA buffer containing 10 ml protease inhibitor
cocktail per 100 mg brain tissue. The homogenates were placed
on ice for 30 min. After centrifugation at 13,500 rpm at 4°C for
30 min, the supernatants were collected. The cells were seeded in
6-well plates and treated with or without harmine. After being
washed three times with PBS, the cells were lysed with RIPA
buffer containing 1% protease inhibitor cocktail. The
concentrations of the protein samples were assessed with the
BCA kit according to the manufacturer's instructions. The
proteins were separated on 10% SDS gels, transferred onto NC
membranes, and incubated in 5% bovine serum albumin for 2 h.
The membranes were incubated with primary antibodies against
nucleotide-binding oligomerization domain-containing protein
(NOD)-like receptor family, pyrin domain containing 3
(NLRP3) (1:500, Bioss, China), adaptor protein apoptosis-
associated speck-like protein (ASC) (1:200, Abcam, USA),
caspase-1 (1:200, Abcam, USA), interleukin-18 (IL-18) (1:200,
Abcam, USA), IL-1b (1:200, Abcam, USA), brain-derived
neurotrophic factor (BDNF) (1:500, Bioss, China), TrkB (1:500,
Bioss, China), phosphorylated TrkB (p-TrkB) (1:200, Bioss,
China), and GAPDH (1:1000) 4°C overnight. On the next day,
the membranes were incubated with secondary antibodies at
room temperature for 1 h. The bands were captured on the
Odyssey Infrared Imaging System (LI-COR) and quantified with
Odyssey software by measuring the band intensity (area × OD)
and normalizing it to that of GAPDH.
Immunofluorescence Analysis
The cells were fixed in 4% paraformaldehyde, permeabilized, and
blocked in 10% serum with 0.01% triton for 1 h at room
temperature. The samples were then incubated with primary
antibodies against NLRP3 (1:200, Bioss, China) and BDNF
(1:200, Bioss, China) overnight at 4°C. An undiluted Alexa
Fluor® 568 (red)-conjugated goat anti-rabbit IgG or Alexa
Fluor® 488 (green)-conjugated anti-rabbit IgG secondary
antibody was used. Images were captured with a Zeiss
microscope and quantified with Image Pro Plus 6 software.
Immunohistochemical Staining
Rats from the different groups (n = 3 in each group) were
anesthetized with 10% chloral hydrate (500 mg/kg,
intraperitoneal), and the whole body of each rat was perfused
through the left ventricle with 4% paraformaldehyde (pH 7.4).
The cortex and hippocampi were removed from the brain of each
rat and fixed in 4% paraformaldehyde overnight at 4°C. After
dehydration in a concentration gradient of ethanol solutions and
dimethylbenzene, the brain tissue samples were embedded inFrontiers in Pharmacology | www.frontiersin.org 3paraffin and cut into 5-mm-thick cross sections. The specimens
were then deparaffinized and blocked with bovine serum
albumin. The following primary antibodies were used in this
study: NLRP3 (1:200, Bioss, China), caspase-1 (1:200, Abcam,
USA), IL-18 (1:200, Abcam, USA), and IL-1b (1:200, Abcam,
USA). Incubation was performed overnight at 4°C. After
incubation with secondary antibodies at 37°C for 30 min, the
sections were stained with diaminobenzidine and hematoxylin.
Images were captured by microscopy (Zeiss, Germany). Ten
images per rat were randomly selected, and at least thirty images
per group were analyzed to determine the ratio of positive signal/
image by using Image Pro Plus 6 software.
Statistical Analysis
The data are expressed as the mean ± SEM. One-way repeated
measure analysis of variance (ANOVA) was used to analyze
differences in day-to-day performance in the MWM test.
Student's t-test was used to analyze the differences between two
groups. All statistical analyses were performed with SPSS 22.0
software. P < 0.05 was considered statistically significant.RESULTS
Harmine Ameliorates Learning and
Memory Impairment in STZ-Induced
Diabetic Rats
To examine the effect of harmine on the learning and memory
abilities of streptozocin (STZ)-induced diabetic rats, we subjected
different groups of rats to the Morris water maze test. As
illustrated in Figure 1A, in the training session, the diabetic rats
swam a longer distance to reach the hidden platform than the
non-diabetes (ND) rats. However, harmine administration
significantly shortened the swimming distance of the diabetic
rats. Moreover, the diabetic rats exhibited a longer escape latency
than the ND rats, and this increase in escape latency was reversed
by harmine administration (Figure 1B). In the probe trial, the
number of platform crossings in the target quadrant exhibited by
the diabetic rats was decreased compared with that exhibited by
the ND rats. In addition, the diabetic rats spent less time in the
target quadrant than the ND rats. Importantly, harmine
administration increased both the number of platform crossings
and the time spent in the target quadrant compared with those
exhibited by the diabetic rats (Figures 1C, D). These data
indicated that harmine can ameliorate learning and memory
impairments induced by diabetes.
Harmine Reduces NLRP3 Inflammasome
Activation in STZ-Induced Diabetic Rats
Next, we aimed to evaluate the effect of harmine on the
nucleotide-binding oligomerization domain-containing protein
(NOD)-like receptor family, pyrin domain containing 3
(NLRP3) inflammasome activation in STZ-induced diabetic
rats. As shown in Figures 2A, C, the levels of major NLRP3
inflammasome components and effectors, including the NLRP3
receptor and the adaptor protein apoptosis-associated speck-likeMay 2020 | Volume 11 | Article 535
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FIGURE 2 | The effect of harmine on the NLRP3 inflammasome in streptozotocin (STZ)–induced diabetic rats. (A–F) Western blot analysis of NLRP3, ASC, cl.casp-
1, IL-1b, and IL-18 levels in the cortex of STZ-induced diabetic rats after harmine administration. Western blot images (A) and related histograms (B–F). n =3 in each
group. *P < 0.05 vs sham, #P < 0.05 vs DM. (G) Immunohistochemical staining analysis showed that harmine reduced the expression of NLRP3, casp-1, IL-1b, and
IL-18 in the cortex of diabetic rats. (H) Histogram of the data in G. DM, diabetes mellitus; casp-1, caspase-1; cl. casp-1, cleaved caspase-1; Har, harmine;
ND, non-diabetes.A B
C D
FIGURE 1 | Harmine ameliorates learning and memory impairments in streptozotocin (STZ)–induced diabetic rats. (A) Distances to platform in the different groups
on day 1 to day 5 were compared (ANOVA: Day 1: P = 0.535; Day 2: P = 0.18; Day 3: P = 0.005; Day 4: P = 0.005; Day 5: P = 0.031). (B) Latencies for the rats in
the different groups to reach the platform on day 1 to day 5 were compared (ANOVA: Day 1: P = 0.127; Day 2: P = 0.133; Day 3: P = 0.034; Day 4: P = 0.041; Day
5: P = 0.034). (C) The number of platform crossings in target quadrant in the probe trial. n = 6 in each group. *P < 0.05 vs sham, #P < 0.05 vs DM. (D) The
percentage of time spent in target quadrant in the probe trial. n = 6 rats in each group. *P < 0.05 vs sham, #P < 0.05 vs DM. DM, diabetes mellitus; Har, harmine;
ND, non-diabetes.Frontiers in Pharmacology | www.frontiersin.org May 2020 | Volume 11 | Article 5354
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diabetic rats compared with the ND rats. Moreover, NLRP3
inflammasome activation was observed in the diabetic rats, as
demonstrated by higher levels of cleaved caspase-1, interleukin
(IL)-1b, and IL-18. Importantly, we found that these changes were
markedly reversed by harmine administration (Figures 2A, D–F).
Moreover, immunohistochemical analysis further confirmed that
the levels of the NLRP3 receptor, caspase-1, IL-1b, and IL-18 were
significantly decreased by harmine treatment (Figures 2G, H).
These results suggested that harmine can inhibit NLRP3
inflammasome activation in STZ-induced diabetic rats.
Effect of Harmine on NLRP3
Inflammasome Activation in HG-Treated
SH-SY5Y Cells
To further observe the function of harmine on NLRP3 inflammasome
activation, western blotting and immunofluorescence were used to
assess changes in the NLRP3 inflammasome in high glucose
(HG)-treated neuronal cells treated with or without harmine. As
shown in Figures 3A–C, the expression of NLRP3 and ASC was
found to be markedly higher in the HG-treated cells than in the
control cells, and this increase in expression was reversed by
harmine treatment. Moreover, HG conditions significantly
upregulated cleaved caspase-1, IL-1b, and IL-18 levels. However,
this effect was blocked by harmine treatment (Figures 3A, D–F).
A similar change in NLRP3 was also observed by
immunofluorescence (Figures 3G, H). These results suggested
that harmine can inhibit NLRP3 inflammasome activation in HG-
treated neuronal cells.Frontiers in Pharmacology | www.frontiersin.org 5Harmine Significantly Enhances BDNF/
TrkB Signaling Both In Vivo and In Vitro
Previous studies have shown that BDNF/TrkB signaling is involved
in the progression of diabetes-induced cognitive dysfunction. To
determine the effect of harmine on BDNF/TrkB signaling, we
measured the changes in BDNF and TrkB in the different groups.
The results showed that STZ injection significantly reduced the level
of BDNF in the brains of rats, and that this effect was reversed by
harmine treatment (Figures 4A, B). As shown in Figure 4C, the
level of phosphorylated TrkB (p-TrkB) was also lower in the DM
group than in the ND group. However, the harmine-treated rats
exhibited a higher level of p-TrkB than the DM rats.
In addition, we detected the effect of harmine on BDNF/TrkB
signaling in vitro. Using western blotting, we found that the level of
BDNF was much lower in the HG-treated cells than in the control
cells, and was upregulated by harmine treatment (Figure 5A). Similar
changes in BDNF were also observed by immunofluorescence
(Figures 5B, C). Furthermore, we observed that the harmine-
treated cells exhibited a higher level of p-TrkB than the HG-treated
cells (Figure 5D). These data demonstrated that harmine can
enhance the BDNF/TrkB signaling pathway both in vivo and in vitro.DISCUSSION
The present study is the first to demonstrate that harmine can
attenuate cognitive dysfunction in STZ-induced diabetic rats.
Moreover, harmine was found to inhibit NLRP3 inflammasomeA B
C D
E F
G
H
FIGURE 3 | The effect of harmine on the NLRP3 inflammasome in high glucose (HG)–treated cells. (A–F) Western blot analysis of NLRP3, ASC, cl. casp-1, IL-1b,
and IL-18 levels in HG-treated SH-SY5Y cells after harmine administration. Western blot images (A) and related histograms (B–F). *P < 0.05 vs sham, #P < 0.05 vs
HG. The data are presented as the mean ± SEM of 4 batches of cells per group. (G) Representative images showing staining for NLRP3 (red) and DAPI (blue) after
exposure to harmine. (H) Histogram of the data in G. HG, high glucose; casp-1, caspase-1; cl. casp-1, cleaved caspase-1; Har, harmine.May 2020 | Volume 11 | Article 535
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both STZ-induced diabetic rats and HG-treated neuronal cells.
Recently, studies have demonstrated a strong relationship
between DM and dementia. Aging, hyperglycemia, insulin
resistance, and inflammation are considered common
pathogenic factors for DM and dementia. For example,
hyperglycemia has been implicated as an important factor in
neuronal cell death, synaptic plasticity dysfunction, and learning
and memory impairment (Chen et al., 2019). Insulin resistance is
involved in the progression of cognitive dysfunction through
promoting Ab accumulation and tau aggregation. Moreover,
growing evidence suggests that inflammation plays a vital role
in the relationship between DM and dementia. It has been found
that the levels of inflammation-related markers, such as IL-1b,
IL-18, and IL-6, are increased in both DM and dementia patients.Frontiers in Pharmacology | www.frontiersin.org 6Notably, IL-1b has been found to be associated with Ab
accumulation, tau hyperphosphorylation, b cell proliferation,
and insulin secretion (Boni-Schnetzler et al., 2018; Li et al.,
2020). It is widely acknowledged that NLRP3 inflammasome
activation contributes to DM and dementia by triggering IL-1b
maturation. NLRP3 inflammasome activation along with
cognitive dysfunction has been observed in diabetic mice (Zhai
et al., 2018). NLRP3 inflammasome inhibition improves
cognitive dysfunction in diabetic rats following stroke (Ward
et al., 2019). HG conditions can induce NLRP3 inflammasome
activation in HT22 cells (Ward and Ergul, 2016). Concordant
with previous findings, we found that the NLRP3 inflammasome
was more strongly activated in the brains of the diabetic rats than
the ND rats, as evidenced by the increased concentrations of
NLRP3, ASC, caspase-1, IL-1b, and IL-18. Importantly, harmineA C
B
FIGURE 4 | The effect of harmine on brain-derived neurotrophic factor (BDNF)/TrkB in vivo. (A) Harmine increased the level of BDNF in the cortex of streptozotocin
(STZ)–induced diabetic rats, as detected by western blotting. Top, western blot images of BDNF. Bottom, related histogram. n = 3 in each group. *P < 0.05 vs sham,
#P < 0.05 vs DM. (B) Immunohistochemical analysis of BDNF in the hippocampi of diabetic rats after harmine treatment. Lower right panel, quantification of the BDNF-
positive area in the brain. (C) Western blot analysis of p-TrkB in the cortex of STZ-induced diabetic rats after harmine treatment. Top, western blot images. Bottom,
related histogram. n = 3 in each group. *P < 0.05 vs sham, #P < 0.05 vs DM. DM, diabetes mellitus; Har, harmine; p-TrkB, phosphorylated TrkBl; ND, non-diabetes.May 2020 | Volume 11 | Article 535
Liu et al. Harmine Ameliorates DM Cognitive Declineadministration significantly inhibited NLRP3 inflammasome
activation and improved cognitive dysfunction in the diabetic
rats. We also observed that HG conditions induced NLRP3
inflammasome activation and IL-1b and IL-18 maturation in
SH-SY5Y neuronal cells, and that this effect was also blocked by
harmine treatment. These results thus demonstrate that harmine
exerts a neuroprotective effect by influencing the NLRP3
inflammasome both in vivo and in vitro.
The neurotrophic factor brain-derived neurotrophic factor
(BDNF)/TrkB signaling pathway contributes to neuronal
migration, neuronal survival, synaptic plasticity, and memory
(Carabalona et al., 2016; Tomassoni-Ardori et al., 2019).
Decreased levels of BDNF and TrkB are observed in rats with
diabetes-induced cognitive dysfunction. However, enhancement of
the BDNF/TrkB pathway alleviates cognitive impairment in
diabetic rats (Yang and Gao, 2017) and protects against neuronal
apoptosis and synaptic plasticity dysfunction under HG conditions
(Zhong et al., 2019). Recent studies have established a link between
the NLRP3 inflammasome and BDNF. IL-1b can suppress BDNF-
dependent synaptic plasticity and cognitive decline through
disturbing the BDNF signaling pathway (Tapia-Arancibia et al.,
2008; Tong et al., 2012). Notably, NLRP3 inflammasome inhibition
can upregulate BDNF expression by suppressing IL-1b (Fu et al.,
2020). Consistent with previous studies, our data showed that
BDNF levels were downregulated by DM, and upregulated by
harmine administration. In addition, TrkB (BDNF receptor) levels
were reduced in the diabetic group than in the control group.
Importantly, harmine administration inhibited the NLRP3
inflammasome, significantly enhanced the BDNF/TrkB signaling
pathway and ameliorated cognitive dysfunction in diabetic rats.
Our study provides evidence to show that harmine can
mitigate cognitive impairment in STZ-induced diabetic rats
and exert neuroprotective effects through inhibiting NLRP3Frontiers in Pharmacology | www.frontiersin.org 7inflammasome activation and enhancing the BDNF/TrkB
signaling pathway. We thus provide novel insight and potential
targets for diabetes-induced cognitive dysfunction.DATA AVAILABILITY STATEMENT
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